Our legal battle against the FTC continues.
Read the full story: Law360 An administrative law judge has postponed until May 5 the resumption of proceedings in the Federal Trade Commission’s closely watched data security fight with LabMD Inc., marking the latest delay in a case that has been on hold for almost a year. In an […]
Read the full story: Law360 The Eleventh Circuit’s refusal to weigh in on a complaint from the Federal Trade Commission accusing LabMD Inc. of failing to safeguard patient information unlawfully shifts the balance of power between agencies and courts, the company recently said in a request for an en banc […]
The House Committee on Oversight and Government Reform’s report of its investigation of Tiversa is now available.
Agency Threatens the Integrity of FOIA, Conduct Part of a Larger Pattern
Read the full story: Law360 The order pointed out that the judge had already rejected a motion by the FTC in July for permission to develop evidence to rebut Wallace’s expected testimony because he had yet to testify, and that Tiversa’s “attempt at anticipatory rebuttal” suffered from a similar defect. […]
All we’ve wanted since we began this case is for the facts and the truth to come out about the FTC’s overreach against LabMD.
This is why it has investigated and litigated for LabMD to stop the FTC from arbitrarily expanding and abusing its power by victimizing an entrepreneur who did nothing wrong
Read the briefing book: Power-Hungry FTC Bureaucrats: Defending Small Business against Administrative Overreach
On June 11, 2014 Congress’s chief watchdog, the House Committee on Oversight and Government Reform, advised the Federal Trade Commission (FTC) that the information the FTC obtained from Tiversa, Inc. is “false,” “incomplete” and “inaccurate.”